• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ephs 和 Ephrins 在癌症中的作用:Ephrin-A1 信号通路。

Ephs and ephrins in cancer: ephrin-A1 signalling.

机构信息

Department of Neurosurgery, Brain Tumor Center of Excellence, Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

出版信息

Semin Cell Dev Biol. 2012 Feb;23(1):109-15. doi: 10.1016/j.semcdb.2011.10.019. Epub 2011 Oct 25.

DOI:10.1016/j.semcdb.2011.10.019
PMID:22040911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3288643/
Abstract

Ephrin-A1 and its primary receptor, EphA2, are involved in numerous physiological processes and have been intensely studied for their roles in malignancy. Ephrin-Eph signalling is complex on its own and is also cell-type dependent, making elucidation of the exact role of ephrin-A1 in neoplasia challenging. Multiple oncogenic signalling pathways, such as MAP/ERK and PI3K are affected by ephrin-A1, and in some cases evidence suggests the promotion of a specific pathway in one cell or cancer type and inhibition of the same pathway in another type of cell or cancer. Ephrin-A1 also plays an integral role in angiogenesis and tumor neovascularization. Until recently, studies investigating ephrins focused on the ligands as GPI-anchored proteins that required membrane anchoring or artificial clustering for Eph receptor activation. However, recent studies have demonstrated a functional role for soluble, monomeric ephrin-A1. This review will focus on various forms of ephrin-A1-specific signalling in human malignancy.

摘要

Ephrin-A1 及其主要受体 EphA2 参与了许多生理过程,并因其在恶性肿瘤中的作用而受到深入研究。Ephrin-Eph 信号本身就很复杂,而且还依赖于细胞类型,这使得阐明 Ephrin-A1 在肿瘤发生中的确切作用具有挑战性。多种致癌信号通路,如 MAP/ERK 和 PI3K,受 Ephrin-A1 影响,在某些情况下,有证据表明 Ephrin-A1 在一种细胞或癌症类型中促进特定通路,而在另一种类型的细胞或癌症中抑制相同通路。Ephrin-A1 还在血管生成和肿瘤新生血管形成中发挥重要作用。直到最近,研究 Ephrins 的研究还集中在作为 GPI 锚定蛋白的配体上,这些配体需要膜锚定或人工聚类才能激活 Eph 受体。然而,最近的研究表明可溶性单体 Ephrin-A1 具有功能作用。这篇综述将重点介绍 Ephrin-A1 在人类恶性肿瘤中的各种特定信号形式。

相似文献

1
Ephs and ephrins in cancer: ephrin-A1 signalling.Ephs 和 Ephrins 在癌症中的作用:Ephrin-A1 信号通路。
Semin Cell Dev Biol. 2012 Feb;23(1):109-15. doi: 10.1016/j.semcdb.2011.10.019. Epub 2011 Oct 25.
2
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.埃菲林-A1配体及其受体EphA2在肿瘤新生血管形成过程中表达。
Oncogene. 2000 Dec 7;19(52):6043-52. doi: 10.1038/sj.onc.1204004.
3
Roles of EphA1/A2 and ephrin-A1 in cancer.EphA1/A2 和 ephrin-A1 在癌症中的作用。
Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15.
4
Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.Ephrin-A1 糖基化的生物学和结构特征,EphA2 受体酪氨酸激酶的首选配体。
J Biol Chem. 2013 Jun 21;288(25):18448-57. doi: 10.1074/jbc.M113.464008. Epub 2013 May 9.
5
The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.EphA1 受体酪氨酸激酶在几种肿瘤中的功能。
Curr Med Chem. 2023;30(20):2340-2353. doi: 10.2174/0929867329666220820125638.
6
EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.在支撑膜上,单体 Ephrin-A1 激活 EphA2 受体。
Biophys J. 2011 Dec 7;101(11):2731-9. doi: 10.1016/j.bpj.2011.10.039.
7
The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.实体瘤中的EphA2受体和ephrinA1配体:功能与治疗靶点
Mol Cancer Res. 2008 Dec;6(12):1795-806. doi: 10.1158/1541-7786.MCR-08-0244.
8
Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.Ephrin-A1 通过诱导肿瘤抑制基因 Cdx-2 抑制 NSCLC 肿瘤生长。
BMC Cancer. 2012 Jul 23;12:309. doi: 10.1186/1471-2407-12-309.
9
Receptor-binding domain of ephrin-A1: production in bacterial expression system and activity.Ephrin-A1 受体结合域:在细菌表达系统中的生产和活性。
Biochemistry (Mosc). 2012 Dec;77(12):1387-94. doi: 10.1134/S0006297912120073.
10
Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury.Eph/ephrin 信号在脂多糖诱导的肠道损伤中起双向作用。
Mol Med Rep. 2018 Aug;18(2):2171-2181. doi: 10.3892/mmr.2018.9169. Epub 2018 Jun 14.

引用本文的文献

1
Increased Serum EphA2 is Associated with Disease Severity in Pediatric Patients with Asthma.血清EphA2升高与小儿哮喘患者的疾病严重程度相关。
J Asthma Allergy. 2025 Apr 8;18:529-537. doi: 10.2147/JAA.S515475. eCollection 2025.
2
Ephrin A1 functions as a ligand of EGFR to promote EMT and metastasis in gastric cancer.Ephrin A1作为表皮生长因子受体(EGFR)的配体,促进胃癌中的上皮-间质转化(EMT)和转移。
EMBO J. 2025 Mar;44(5):1464-1487. doi: 10.1038/s44318-025-00363-x. Epub 2025 Jan 21.
3
RSK4 promotes the metastasis of clear cell renal cell carcinoma by activating RUNX1-mediated angiogenesis.

本文引用的文献

1
EphrinA1 stimulates cell attachment and inhibits cell aggregation through the EphA receptor pathway in human endometrial carcinoma-derived Ishikawa cells.EphrinA1 通过 EphA 受体途径刺激人子宫内膜癌细胞衍生的 Ishikawa 细胞的黏附并抑制细胞聚集。
Hum Reprod. 2011 May;26(5):1163-70. doi: 10.1093/humrep/der034. Epub 2011 Feb 23.
2
Emerging strategies for EphA2 receptor targeting for cancer therapeutics.针对癌症治疗的 EphA2 受体靶向新兴策略。
Expert Opin Ther Targets. 2011 Jan;15(1):31-51. doi: 10.1517/14728222.2011.538682.
3
Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.
RSK4通过激活RUNX1介导的血管生成促进透明细胞肾细胞癌的转移。
Cancer Biol Ther. 2025 Dec;26(1):2452025. doi: 10.1080/15384047.2025.2452025. Epub 2025 Jan 10.
4
Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review.揭示EphA2在胶质母细胞瘤中的治疗前景:一项全面综述
Discov Oncol. 2024 Sep 27;15(1):501. doi: 10.1007/s12672-024-01380-8.
5
Targeting the EphA2 pathway: could it be the way for bone sarcomas?靶向 EphA2 通路:这可能是骨肉瘤的治疗途径?
Cell Commun Signal. 2024 Sep 9;22(1):433. doi: 10.1186/s12964-024-01811-7.
6
EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections.Epha2 受体作为病毒感染的潜在治疗靶点。
Curr Med Chem. 2024;31(35):5670-5701. doi: 10.2174/0109298673256638231003111234.
7
Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling.人类疱疹病毒 8 对 Ephrin 配体的分子模拟促进细胞进入并触发 EphA2 信号转导。
PLoS Biol. 2021 Sep 9;19(9):e3001392. doi: 10.1371/journal.pbio.3001392. eCollection 2021 Sep.
8
Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.耐药性癌细胞衍生的外泌体 EphA2 通过 EphA2-Ephrin A1 反向信号促进乳腺癌转移。
Cell Death Dis. 2021 Apr 20;12(5):414. doi: 10.1038/s41419-021-03692-x.
9
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?EphA2与表皮生长因子受体(EGFR):生命中的伙伴,致病的搭档。EphA2能否成为抗EGFR药物反应的预测性生物标志物?
Cancers (Basel). 2021 Feb 9;13(4):700. doi: 10.3390/cancers13040700.
10
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas.SLIT2对EPHA2-ROBO1异二聚体的激活减弱了鳞状细胞癌中的非经典信号传导和增殖。
iScience. 2020 Oct 16;23(11):101692. doi: 10.1016/j.isci.2020.101692. eCollection 2020 Nov 20.
Slit2 和 Ephrin-A1 之间的协同信号转导调节血管生成和血管抑制之间的平衡。
Mol Cell Biol. 2011 Feb;31(3):404-16. doi: 10.1128/MCB.00667-10. Epub 2010 Dec 6.
4
Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells.可溶性 EphrinA1 对于 HeLa 和 SK-BR3 细胞的生长是必需的。
Cancer Cell Int. 2010 Oct 27;10:41. doi: 10.1186/1475-2867-10-41.
5
Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.EphA2 受体与丝氨酸/苏氨酸磷酸酶的串扰抑制癌细胞中的 Akt-mTORC1 通路。
Cell Signal. 2011 Jan;23(1):201-12. doi: 10.1016/j.cellsig.2010.09.004. Epub 2010 Sep 15.
6
Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations.配体结合域的晶体结构揭示了杂乱 EphA4 受体的两种不同构象。
Biochem Biophys Res Commun. 2010 Sep 3;399(4):555-9. doi: 10.1016/j.bbrc.2010.07.109. Epub 2010 Aug 1.
7
Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Eph 受体及其配体在癌症中的作用:双向信号传递及其他。
Nat Rev Cancer. 2010 Mar;10(3):165-80. doi: 10.1038/nrc2806.
8
A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.Hic1 通过转录抑制 Ephrin-A1 在乳腺癌中发挥潜在的肿瘤抑制作用。
Oncogene. 2010 Apr 29;29(17):2467-76. doi: 10.1038/onc.2010.12. Epub 2010 Feb 15.
9
The role of Eph receptors and ephrin ligands in colorectal cancer.Eph 受体和 Ephrin 配体在结直肠癌中的作用。
Int J Cancer. 2010 May 1;126(9):2003-11. doi: 10.1002/ijc.25147.
10
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.受体酪氨酸激酶 EphA2 的升高介导了曲妥珠单抗治疗的耐药性。
Cancer Res. 2010 Jan 1;70(1):299-308. doi: 10.1158/0008-5472.CAN-09-1845. Epub 2009 Dec 22.